Evolent Health Inc reports results for the quarter ended in March - Earnings Summary

Evolent Health

04/05/2023 02:10

* Evolent Health Inc  EVH.N  reported quarterly adjusted
earnings
of 21 cents​​ per share for the quarter ended in March. The mean
expectation of ten analysts for the quarter was for earnings of
20 cents per share.
    * Revenue rose 44% to $427.69 million from a year ago;
analysts
expected $434.34 million. 
    * Evolent Health Inc's reported EPS for the quarter was a
loss
of 24 cents​.
    * The mean earnings estimate of analysts had risen by
about 87.5%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * Evolent Health Inc shares had risen by 8.0% this
quarter and
gained 24.8% so far this year.
    * The company reported a quarterly loss of $26.26 million.
    * Wall Street's median 12-month price target for Evolent
Health
Inc is $46.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
4 at 01:10 a.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      0.20           0.21           Beat
 Dec. 31 2022      0.16           0.10           Missed
 Sep. 30 2022      0.12           0.59           Beat
 Jun. 30 2022      0.05           0.10           Beat